Clinical utility and limitation of FDG-PET in detecting recurrent HCC

被引：0
|
作者：
Hayakawa, Nobuyuki [1 ]
Nakamoto, Yuji [1 ]
Higashi, Tatsuya [2 ]
Togashi, Kaori [1 ]
机构：
[1] Kyoto Univ, Diagnost Imaging & Nucl Med, Kyoto, Japan
[2] Shiga Med Ctr, Res Inst, Moriyama, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1297
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A multi-center trial to evaluate the clinical utility of FDG-PET
    Foster, NL
    Koeppe, RA
    Rogers, V
    Minoshima, S
    Clark, CM
    Jagust, WJ
    Arnold, SE
    Barbas, NR
    DeCarli, CS
    Heidebrink, JL
    Turner, RS
    Higdon, R
    NEUROBIOLOGY OF AGING, 2004, 25 (02) : 246 - 246
  • [22] Limitations of FDG-PET and FDG-PET With Computed Tomography for Detecting Synchronous Cancer in Pharyngeal Cancer
    Suzuki, Hidenori
    Hasegawa, Yasuhisa
    Terada, Akihiro
    Ogawa, Tetsuya
    Hyodo, Ikuo
    Suzuki, Masahiro
    Nakashima, Tsutomu
    Tamaki, Tsuneo
    Nishio, Masami
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 134 (11) : 1191 - 1195
  • [23] Clinical Utility of FDG-PET and PET/CT in Non-malignant Thoracic Disorders
    Basu, Sandip
    Saboury, Babak
    Werner, Tom
    Alavi, Abass
    MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (06) : 1051 - 1060
  • [24] CLINICAL IMPACT OF FDG-PET IN PATIENTS WITH SUSPECTED RECURRENT OVARIAN CANCER
    Cuenca Cuenca, J. I.
    Borrego Dorado, I.
    Vazquez Albertino, R.
    Gomez Camarero, P.
    Sanz Viedma, S.
    Fernandez Lopez, R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2008, 27 (06): : 411 - 417
  • [25] The potential clinical value of FDG-PET for recurrent renal cell carcinoma
    Nakatani, Koya
    Nakamoto, Yuji
    Saga, Tsuneo
    Higashi, Tatsuya
    Togashi, Kaori
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 79 (01) : 29 - 35
  • [26] Clinical impact of FDG-PET for assessment of recurrent malignant lymphoma.
    Yamamoto, Y
    Nishiyama, Y
    Monden, T
    Nagai, M
    Satoh, K
    Ohkawa, M
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 418P - 418P
  • [27] The clinical impact of FDG-PET in the management of recurrent breast cancer.
    Shankar, LK
    Oberhofer, MT
    Ziessman, HA
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 297P - 297P
  • [28] The clinical role of FDG-PET in the management of residual and/or recurrent ovarian carcinoma
    Alavi, A
    Mangan, C
    Morgan, M
    Bhatnagar, A
    Eisenberg, D
    Rubin, S
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 249P - 249P
  • [29] The utility of FDG-PET in the differential diagnosis of Parkinsonism
    Brajkovic, Leposava
    Kostic, Vladimir
    Sobic-Saranovic, Dragana
    Stefanova, Elka
    Jecmenica-Lukic, Milica
    Jesic, Ana
    Stojiljkovic, Milica
    Odalovic, Strahinja
    Gallivanone, Francesca
    Castiglioni, Isabella
    Radovic, Branislava
    Trajkovic, Goran
    Artiko, Vera
    NEUROLOGICAL RESEARCH, 2017, 39 (08) : 675 - 684
  • [30] Utility of FDG-PET in primary renal lymphoma
    Bahure, Sarita
    Cheung, Joshua Chun Yin
    Lin, Michael
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 158 - 159
12345